1/30/2025 | SP | New Issue: GS Finance prices $3.32 million autocallable variable coupon equity notes on four stocks
|
7/24/2024 | SP | New Issue: UBS prices $100,000 buffered return optimization securities linked to Vertex
|
3/26/2023 | SP | New Issue: UBS prices $100,000 buffered return optimization securities linked to Vertex
|
10/25/2022 | SP | New Issue: RBC sells $190,000 thematic opportunity notes on 16 Top 30 Global Ideas stocks
|
8/18/2022 | SP | New Issue: GS Finance prices $500,000 callable contingent coupon equity notes on Vertex
|
4/29/2022 | SP | New Issue: GS Finance sells $9.25 million basket-linked notes tied to 77 stocks
|
3/7/2022 | SP | New Issue: UBS prices $1.25 million trigger phoenix autocallables linked to Vertex
|
8/26/2021 | SP | New Issue: GS Finance prices $13.14 million leveraged basket-linked notes on 179 stocks
|
8/26/2021 | SP | New Issue: TD Bank prices $675,000 callable contingent interest barrier notes on Vertex
|
8/23/2021 | SP | New Issue: JPMorgan sells $630,000 autocallable contingent interest notes on three stocks
|
1/4/2021 | SP | New Issue: UBS prices $2.15 million trigger autocallable contingent yield notes on Vertex
|
12/29/2020 | SP | New Issue: GS Finance sells $1.71 million leveraged basket-linked notes on 23 stocks
|
12/19/2020 | SP | New Issue: Credit Suisse prices $2.8 million Accelerated Return Equity Securities on stock basket
|
12/19/2020 | SP | New Issue: Credit Suisse prices $1.43 million Accelerated Return Equity Securities on stock basket
|
12/18/2020 | SP | New Issue: TD Bank prices $10 million contingent interest buffer autocallables linked to Vertex
|
11/13/2019 | SP | New Issue: GS Finance prices $1.13 million contingent coupon autocallables linked to three stocks
|
11/13/2019 | SP | New Issue: GS Finance prices $1.94 million contingent coupon autocallables linked to three stocks
|
11/1/2019 | SP | GS Finance to price contingent coupon notes linked to three stocks
|
11/1/2019 | SP | GS Finance plans contingent coupon autocallables tied to three stocks
|
10/31/2018 | SP | New Issue: BMO sells $292,000 notes on eight Raymond James biotechnology top picks
|
10/31/2018 | SP | New Issue: BMO sells $390,000 notes on eight Raymond James biotechnology top picks
|
10/11/2018 | SP | BMO plans notes due 2020 tied to Raymond James biotech top picks
|
10/11/2018 | SP | BMO to price notes due 2020 tied to Raymond James biotech top picks
|
10/8/2018 | SP | New Issue: BMO sells $1.23 million notes on eight Raymond James Biotechnology Sector top picks
|
10/8/2018 | SP | New Issue: BMO sells $1.02 million notes on eight Raymond James Biotechnology Sector top picks
|
4/3/2018 | SP | New Issue: JPMorgan sells $2.05 million 19.75% contingent interest autocalls tied to three stocks
|
4/3/2018 | SP | New Issue: JPMorgan sells $1.68 million 18% contingent interest autocalls tied to three stocks
|
4/2/2018 | SP | New Issue: CIBC sells $495,000 notes on eight Raymond James top pick healthcare stocks
|
4/2/2018 | SP | New Issue: CIBC sells $285,000 Raymond James Healthcare Top Selections notes on 16 stocks
|
4/2/2018 | SP | New Issue: CIBC sells $548,000 notes on eight Raymond James top pick healthcare stocks
|
3/26/2018 | SP | New Issue: Barclays prices $864,000 phoenix autocalls tied to Facebook, Vertex, Citi
|
3/21/2018 | SP | Barclays to price phoenix autocallables tied to Facebook, Vertex, Citi
|
3/20/2018 | SP | CIBC plans notes on eight Raymond James top pick healthcare stocks
|
3/20/2018 | SP | CIBC to price notes on eight Raymond James top pick healthcare stocks
|
3/20/2018 | SP | CIBC plans Raymond James Healthcare Top Selections notes on 16 stocks
|
3/20/2018 | SP | CIBC to price notes on 16 Raymond James top pick healthcare stocks
|
3/15/2018 | SP | JPMorgan plans 18% contingent interest autocallables on three stocks
|
2/20/2018 | SP | New Issue: Credit Suisse sells $95,023 call warrants linked to 20 stocks
|
2/16/2018 | SP | New Issue: Credit Suisse sells $149,992 call warrants linked to 20 stocks
|
2/16/2018 | SP | New Issue: Credit Suisse sells $83,500 call warrants linked to 20 stocks
|
2/15/2018 | SP | New Issue: Credit Suisse sells $149,951 call warrants linked to 20 stocks
|
2/15/2018 | SP | New Issue: Credit Suisse sells $175,000 return notes on basket of 20 stocks
|
2/8/2018 | SP | Credit Suisse to price 54-week call warrants linked to 20 stocks
|
2/8/2018 | SP | Credit Suisse to price return notes linked to basket of 20 stocks
|
2/5/2018 | SP | New Issue: JPMorgan sells $5.81 million return notes linked to basket of 20 stocks
|
2/5/2018 | SP | New Issue: Credit Suisse prices $425,971 call warrants linked to 20 stocks
|
1/31/2018 | SP | Credit Suisse to price return notes linked to basket of 20 stocks
|
1/24/2018 | SP | JPMorgan to price return notes linked to basket of 20 stocks
|
1/24/2018 | SP | Credit Suisse to price 54-week call warrants linked to 20 stocks
|
1/24/2018 | SP | New Issue: Credit Suisse prices $639,916 call warrants linked to 20 stocks
|
1/23/2018 | SP | New Issue: Credit Suisse prices $2.79 million return notes on basket of 20 stocks
|
1/18/2018 | SP | Credit Suisse to price return notes linked to basket of 20 stocks
|
11/15/2017 | SP | New Issue: Credit Suisse prices $1.27 million contingent coupon autocallables on three stocks
|
11/15/2017 | SP | New Issue: Credit Suisse prices $935,000 contingent coupon autocallables on three stocks
|
11/9/2017 | SP | Credit Suisse plans 19.25% contingent coupon autocalls tied to stocks
|
11/9/2017 | SP | Credit Suisse plans 20.85% contingent coupon autocalls tied to stocks
|
9/19/2017 | SP | New Issue: Barclays prices $2 million phoenix autocallables linked to three stocks
|
9/19/2017 | SP | New Issue: Barclays sells $1.65 million phoenix autocallables tied to three stocks
|
11/3/2016 | SP | New Issue: JPMorgan prices $6.6 million return notes linked to basket of 50 stocks
|
10/26/2016 | SP | JPMorgan plans one-year return notes linked to basket of 50 stocks
|
9/16/2016 | SP | New Issue: HSBC prices $3 million of AMPS linked to basket of 20 common stocks
|
9/8/2016 | SP | HSBC plans 15-month AMPS with cap linked to basket of 20 stocks
|
3/7/2016 | SP | New Issue: Bank of America prices $2.2 million enhanced return notes on 10 stocks
|
2/29/2016 | SP | Bank of America to price enhanced return notes linked to 10 stocks
|
1/21/2016 | SP | New Issue: Credit Suisse sells $162,000 autocallable reverse convertibles on Vertex
|
1/4/2016 | SP | Credit Suisse plans autocallable reverse convertibles linked to Vertex
|
7/23/2015 | SP | New Issue: HSBC prices $1.41 million 9% one-year autocallable yield notes linked to Vertex
|
7/13/2015 | SP | HSBC plans 9% one-year autocallable yield notes linked to Vertex
|
6/11/2015 | SP | New Issue: JPMorgan prices $3.26 million capped return enhanced notes on S&P 500
|
5/29/2015 | SP | New Issue: Barclays prices $5.25 million 7.1% airbag autocallables on Vertex Pharmaceuticals
|
5/20/2015 | SP | Barclays plans 6%-8% airbag autocallables on Vertex Pharmaceuticals
|
4/14/2015 | SP | New Issue: RBC prices $6.19 million airbag phoenix autocallables linked to Vertex
|
4/7/2015 | SP | RBC to price 9.75%-11.75% airbag phoenix autocallables tied to Vertex
|
4/6/2015 | SP | New Issue: Credit Suisse prices $746,000 10.5% autocallable reverse convertibles linked to Vertex
|
3/16/2015 | SP | Credit Suisse plans 10%-12% autocallable reverse convertibles on Vertex
|
2/27/2015 | SP | New Issue: RBC prices $4.36 million 9.6% airbag autocallables linked to Vertex
|
2/23/2015 | SP | RBC to price 7.8%-9.8% airbag phoenix autocallables linked to Vertex
|
1/30/2015 | SP | New Issue: UBS prices $250,000 trigger phoenix autocallable optimization securities linked to Vertex Pharmaceuticals
|
1/29/2015 | SP | New Issue: UBS prices $225,000 trigger phoenix autocallable optimization securities linked to Vertex Pharmaceuticals
|
12/1/2014 | SP | New Issue: HSBC prices $4.18 million 9% airbag autocallable yield notes on Vertex Pharmaceuticals
|
11/24/2014 | SP | New Issue: RBC prices $25,000 8.75% reverse convertibles linked to Vertex Pharmaceuticals
|
11/20/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Vertex Pharmaceuticals
|
11/20/2014 | SP | HSBC plans 7.4%-9.4% airbag autocallable yield notes linked to Vertex
|
11/18/2014 | SP | New Issue: UBS prices $174,000 trigger phoenix autocallable optimization securities linked to Vertex Pharmaceuticals
|
11/12/2014 | SP | New Issue: JPMorgan prices $173,000 contingent absolute return autocallables on Vertex
|
11/7/2014 | SP | RBC to price 8.75% reverse convertibles linked to Vertex Pharmaceuticals
|
11/5/2014 | SP | JPMorgan plans contingent absolute return autocallables tied to Vertex
|
10/30/2014 | SP | New Issue: RBC prices $159,000 9.7% reverse convertibles linked to Vertex Pharmaceuticals
|
10/21/2014 | SP | New Issue: RBC prices $1.2 million 7.5% airbag autocallable notes linked to Vertex
|
10/14/2014 | SP | RBC to price 6%-7.2% airbag autocallables linked to Vertex
|
10/14/2014 | SP | RBC to price 8.3% reverse convertibles linked to Vertex Pharmaceuticals
|
10/9/2014 | SP | New Issue: UBS prices $335,000 contingent absolute return autocallable optimization securities linked to Vertex Pharmaceuticals
|
9/30/2014 | SP | New Issue: RBC prices $191,000 9% reverse convertibles linked to Vertex Pharmaceuticals
|
9/22/2014 | SP | RBC to price 9% reverse convertibles linked to Vertex Pharmaceuticals
|
9/17/2014 | SP | New Issue: RBC prices $32,000 10.25% reverse convertibles linked to Vertex Pharmaceuticals
|
9/12/2014 | SP | New Issue: UBS prices $427,000 trigger phoenix autocallable optimization securities linked to Vertex Pharmaceuticals
|
9/11/2014 | SP | New Issue: UBS prices $1 million trigger phoenix autocallable optimization securities linked to Vertex Pharmaceuticals
|
9/11/2014 | SP | RBC to price 10.25% reverse convertibles linked to Vertex Pharmaceuticals
|
9/5/2014 | SP | New Issue: UBS prices $937,000 trigger phoenix autocallable optimization securities linked to Vertex Pharmaceuticals
|
9/5/2014 | SP | New Issue: UBS prices $942,000 trigger phoenix autocallable optimization securities linked to Vertex Pharmaceuticals
|
9/3/2014 | SP | New Issue: UBS prices $305,000 trigger phoenix autocallable optimization securities linked to Vertex Pharmaceuticals
|
8/27/2014 | SP | New Issue: UBS prices $6.13 million 8.88% airbag autocallables linked to Vertex
|
8/21/2014 | SP | RBC plans to price 10.8% reverse convertibles linked to Vertex
|
8/20/2014 | SP | New Issue: RBC prices $317,000 11.25% reverse convertibles linked to Vertex
|
8/20/2014 | SP | New Issue: UBS prices $1 million trigger autocallable optimization securities linked to Vertex Pharmaceuticals
|
8/20/2014 | SP | UBS plans to price 7.8%-9.8% airbag autocallables linked to Vertex
|
8/14/2014 | SP | New Issue: UBS prices $189,000 trigger phoenix autocallable optimization securities linked to Vertex Pharmaceuticals
|
8/13/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Vertex Pharmaceuticals
|
8/8/2014 | SP | RBC to price 11.25% reverse convertibles linked to Vertex
|
8/8/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Vertex Pharmaceuticals
|
8/4/2014 | SP | New Issue: UBS prices $150,000 airbag yield optimization notes linked to Vertex Pharmaceuticals
|
7/30/2014 | SP | New Issue: UBS prices $120,000 trigger phoenix autocallable optimization securities linked to Vertex Pharmaceuticals
|
7/24/2014 | SP | New Issue: UBS prices $114,924 7.46% trigger yield optimization notes linked to Vertex Pharmaceuticals
|
7/17/2014 | SP | New Issue: RBC prices $545,000 12.2% reverse convertibles linked to Vertex Pharmaceuticals
|
7/8/2014 | SP | New Issue: UBS prices $106,000 trigger phoenix autocallable optimization securities linked to Vertex Pharmaceuticals
|
7/7/2014 | SP | RBC to price 11.5% reverse convertibles linked to Vertex Pharmaceuticals
|
6/23/2014 | SP | New Issue: UBS prices $126,958 8.89% trigger yield optimization notes linked to Vertex Pharmaceuticals
|
6/19/2014 | SP | New Issue: UBS prices $100,000 airbag yield optimization notes linked to Vertex Pharmaceuticals
|
5/27/2014 | SP | New Issue: UBS prices $100,000 airbag yield optimization notes linked to Vertex Pharmaceuticals
|
5/8/2014 | SP | New Issue: UBS prices $999,937 15.8% trigger yield optimization notes linked to Vertex Pharmaceuticals
|
4/17/2014 | SP | New Issue: UBS prices $175,000 airbag yield optimization notes linked to Vertex Pharmaceuticals
|
4/11/2014 | SP | New Issue: UBS prices $200,000 airbag yield optimization notes linked to Vertex Pharmaceuticals
|
4/11/2014 | SP | New Issue: UBS prices $391,000 airbag yield optimization notes linked to Vertex Pharmaceuticals
|
3/19/2014 | SP | New Issue: UBS prices $149,998 19.48% trigger yield optimization notes linked to Vertex Pharmaceuticals
|
3/6/2014 | SP | New Issue: UBS prices $100,000 airbag yield optimization notes linked to Vertex Pharmaceuticals
|
3/4/2014 | SP | New Issue: UBS prices $100,000 airbag yield optimization notes linked to Vertex Pharmaceuticals
|
2/28/2014 | SP | New Issue: RBC prices $120,000 13.7% reverse convertibles linked to Vertex Pharmaceuticals
|
2/25/2014 | SP | New Issue: UBS prices $239,000 airbag yield optimization notes linked to Vertex Pharmaceuticals
|
2/25/2014 | SP | New Issue: JPMorgan prices $19.44 million 11% airbag autocallables linked to Vertex
|
2/20/2014 | SP | RBC to price 13% reverse convertibles linked to Vertex Pharmaceuticals
|
2/19/2014 | SP | JPMorgan to price 9.25%-11.25% airbag autocallables tied to Vertex
|
2/19/2014 | SP | New Issue: RBC prices $122,000 12.5% reverse convertibles linked to Vertex Pharmaceuticals
|
2/7/2014 | SP | New Issue: UBS prices $110,000 airbag yield optimization notes linked to Vertex Pharmaceuticals
|
2/7/2014 | SP | New Issue: UBS prices $107,000 airbag yield optimization notes linked to Vertex Pharmaceuticals
|
2/4/2014 | SP | RBC to price 12.5% reverse convertibles linked to Vertex Pharmaceuticals
|
1/27/2014 | SP | New Issue: UBS prices $217,000 trigger phoenix autocallable optimization securities linked to Vertex Pharmaceuticals
|
1/23/2014 | SP | New Issue: UBS prices $112,040 trigger phoenix autocallable optimization securities linked to Vertex Pharmaceuticals
|
1/22/2014 | SP | New Issue: UBS prices $730,000 trigger phoenix autocallable optimization securities linked to Vertex Pharmaceuticals
|
1/17/2014 | SP | New Issue: UBS prices $99,985 11.23% trigger yield optimization notes linked to Vertex Pharmaceuticals
|
1/15/2014 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Vertex Pharmaceuticals
|
1/15/2014 | SP | New Issue: UBS prices $130,710 trigger phoenix autocallable optimization securities linked to Vertex Pharmaceuticals
|
1/14/2014 | SP | New Issue: UBS prices $150,000 airbag yield optimization notes linked to Vertex Pharmaceuticals
|
1/14/2014 | SP | New Issue: UBS prices $210,000 airbag yield optimization notes linked to Vertex Pharmaceuticals
|
1/10/2014 | SP | New Issue: UBS prices $183,000 airbag yield optimization notes linked to Vertex Pharmaceuticals
|
1/9/2014 | SP | New Issue: UBS prices $265,000 airbag yield optimization notes linked to Vertex Pharmaceuticals
|
12/17/2013 | SP | New Issue: UBS prices $725,000 airbag yield optimization notes linked to Vertex Pharmaceuticals
|
12/10/2013 | SP | New Issue: UBS prices $99,941 10.91% trigger yield optimization notes linked to Vertex Pharmaceuticals
|
12/9/2013 | SP | New Issue: UBS prices $127,000 trigger phoenix autocallable optimization securities linked to Vertex Pharmaceuticals
|
12/5/2013 | SP | New Issue: UBS prices $529,473 11.18% trigger yield optimization notes linked to Vertex Pharmaceuticals
|
12/4/2013 | SP | New Issue: UBS prices $274,841 11.27% trigger yield optimization notes linked to Vertex Pharmaceuticals
|
12/3/2013 | SP | New Issue: UBS prices $124,900 10.79% trigger yield optimization notes linked to Vertex Pharmaceuticals
|
12/3/2013 | SP | New Issue: UBS prices $105,000 trigger phoenix autocallable optimization securities linked to Vertex Pharmaceuticals
|
11/19/2013 | SP | New Issue: UBS prices $110,000 airbag yield optimization notes linked to Vertex Pharmaceuticals
|
11/15/2013 | SP | New Issue: UBS prices $358,900 trigger phoenix autocallable optimization securities linked to Vertex Pharmaceuticals
|
11/12/2013 | SP | New Issue: Deutsche prices $4.94 million 8.8% airbag autocallable yield notes on Vertex Pharmaceuticals
|
11/6/2013 | SP | Deutsche plans 6.8%-8.8% airbag autocallables on Vertex Pharmaceuticals
|
10/1/2013 | SP | New Issue: UBS prices $104,000 trigger phoenix autocallable optimization securities linked to Vertex Pharmaceuticals
|
8/27/2013 | SP | New Issue: RBC prices $1.81 million airbag yield optimization notes linked to Vertex Pharmaceuticals
|
8/21/2013 | SP | RBC plans 6.5%-8.5% airbag yield optimization notes linked to Vertex
|
2/26/2013 | SP | New Issue: Barclays prices $7.32 million 12.55% airbag notes linked to Vertex Pharmaceuticals
|
2/21/2013 | SP | Barclays plans 9%-11% airbag yield notes tied to Vertex Pharmaceuticals
|
12/20/2012 | SP | New Issue: JPMorgan prices $715,380 contingent absolute return autocallables on Vertex
|
12/12/2012 | SP | JPMorgan plans contingent absolute return autocallables on Vertex
|
10/23/2012 | SP | New Issue: Deutsche Bank prices $1.59 million airbag yield optimization notes linked to Vertex Pharmaceuticals
|
10/17/2012 | SP | Deutsche Bank plans 7%-9.5% airbag notes on Vertex Pharmaceuticals
|
7/9/2012 | SP | New Issue: RBC prices $934,000 10.85% airbag notes linked to Vertex
|
7/2/2012 | SP | RBC plans 8.5%-11% airbag yield optimization notes linked to Vertex
|
2/29/2012 | SP | New Issue: RBC prices $3.38 million 12.94% airbag notes linked to Vertex
|
2/23/2012 | SP | RBC plans 10%-13% airbag yield optimization notes linked to Vertex
|
9/29/2011 | SP | New Issue: Bank of Montreal prices $343,000 14% reverse exchangeables on Vertex
|
9/21/2011 | SP | Bank of Montreal plans 14% reverse exchangeables linked to Vertex
|
8/9/2011 | SP | New Issue: RBC prices $3.02 million 12.75% trigger yield notes linked to Vertex Pharmaceuticals
|
8/2/2011 | SP | RBC plans 9.5%-12% trigger yield optimization notes linked to Vertex
|
7/7/2011 | SP | New Issue: JPMorgan prices $5.29 million 16% reverse convertibles linked to Vertex Pharmaceuticals
|
5/17/2011 | SP | New Issue: Bank of Montreal prices $5,000 12% reverse exchangeables on Vertex
|
5/2/2011 | SP | Bank of Montreal plans 12% reverse exchangeables linked to Vertex
|
4/19/2011 | SP | New Issue: Bank of Montreal prices $742,000 19.15% reverse exchangeables on Vertex
|
3/30/2011 | SP | Bank of Montreal plans 19.15% reverse exchangeables linked to Vertex
|
5/27/2010 | SP | New Issue: Barclays prices $0.25 million 15% reverse convertibles linked to Vertex Pharmaceuticals
|
5/11/2010 | SP | Barclays to price 15% reverse convertibles linked to Vertex Pharmaceuticals
|
4/29/2010 | SP | New Issue: Barclays prices $1 million 11.75% reverse convertibles linked to Vertex Pharmaceuticals
|
4/12/2010 | SP | Barclays to price 11.75% reverse convertibles linked to Vertex Pharmaceuticals
|
3/31/2010 | SP | New Issue: Barclays prices $4 million 10.5% reverse convertibles linked to Vertex Pharmaceuticals
|
3/9/2010 | SP | Barclays to price 10.5% reverse convertibles linked to Vertex Pharmaceuticals
|
3/2/2010 | SP | New Issue: Barclays sells $10 million more 10.25% reverse convertibles linked to Vertex Pharmaceuticals
|
2/25/2010 | SP | New Issue: Barclays prices $2.5 million 10.25% reverse convertibles linked to Vertex Pharmaceuticals
|
2/8/2010 | SP | Barclays to price 10.25% reverse convertibles linked to Vertex Pharmaceuticals
|
2/1/2010 | SP | New Issue: Wells Fargo sells $2.38 million 15% enhanced yield notes on Vertex for Eksportfinans
|
1/29/2010 | SP | New Issue: Barclays prices $2 million 12% reverse convertibles linked to Vertex Pharmaceuticals
|
1/20/2010 | SP | Wells Fargo to price 12%-13% enhanced yield securities linked to Vertex for Eksportfinans
|
1/8/2010 | SP | Barclays to price 12% reverse convertibles linked to Vertex Pharmaceuticals
|
11/5/2007 | SP | Barclays to price 18% reverse convertibles linked to Vertex
|
10/24/2007 | SP | New Issue: RBC prices $1 million of 17.3% reverse convertibles linked to Vertex
|
7/27/2007 | SP | New Issue: ABN Amro prices $500,000 20.3% reverse convertibles linked to Vertex
|
7/26/2007 | SP | New Issue: Barclays prices $1.5 million 19% reverse convertibles linked to Vertex Pharmaceuticals
|
7/10/2007 | SP | Barclays to price 19% reverse convertibles linked to Vertex Pharmaceuticals
|
7/6/2007 | SP | ABN Amro plans 20.30% knock-in notes linked to Vertex Pharmaceuticals
|
7/3/2007 | SP | ABN Amro plans 20.3% reverse exchangeable securities linked to Vertex
|
6/29/2007 | SP | New Issue: Wachovia prices $9.717 million 14.25% enhanced yield securities linked to Vertex
|
6/5/2007 | SP | Rabo to price 12.7% knock-in reverse convertibles linked to Vertex Pharmaceuticals via LaSalle
|
6/1/2007 | SP | Wachovia to price enhanced yield securities linked to Vertex
|
5/22/2007 | SP | Rabo to price 15.5% knock-in reverse convertibles linked to Vertex Pharmaceuticals via LaSalle
|
5/3/2007 | SP | New Issue: Natixis prices $1.15 million 13.75% reverse convertibles linked to Vertex for Eksportfinans
|
5/1/2007 | SP | Rabo to price 15.5% reverse convertibles linked to Vertex
|
4/27/2007 | SP | New Issue: HSBC sells $565,000 29% reverse convertibles linked to Vertex
|
4/13/2007 | SP | Market Commentary: Lehman to price notes linked to Israeli shekel; Barclays plans S&P 500-linked notes
|
4/5/2007 | SP | HSBC to issue 29% reverse convertibles linked to Vertex Pharmaceuticals
|
3/27/2007 | SP | New Issue: HSBC USA prices $3.002 million 29.25% notes linked to Vertex
|
3/6/2007 | SP | HSBC to issue 29.25% reverse convertibles linked to Vertex
|